CDEX is a technology company specializing in advanced chemical detection and validation devices.
Based on its patented Enhanced Photoemission Spectroscopy technology, they provide unique
solutions to the challenges of identifying substances in difficult-to-monitor & critical environments.

Current market channels addressed:

• Medication and drug validation – ValiMed™ Systems
• Illicit drug detection – ID2 product line
• ID2 Meth Scanner – handheld version for detecting meth, used in home inspection and remediation
• Pocket ID2 Scanner – pocket sized detection device detects meth and other illicit drugs, for use in law enforcement and other applicable environments

CDEX’s proprietary systems will be applied in other fields including:

• Homeland security – i.e. explosive detection and illicit drugs
• Brand protection – through fraud identification
• Counterfeit drug identification

Recurring revenue model

• ID2 products – direct product sales and recurring revenue generated through required annual maintenance and recalibration
• Valimed™ systems – direct placement fee with monthly residual and usage fees
• Products are distributed in the market via national and international distributors such as Lifeloc Technologies, Decatur Electronics and independent distributor
• Multi billion dollar market opportunity in several market segments